Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fresno State Athletics and The Wonderful Company Announce First Multi-Brand Partnership Across All Bulldog Sports
-
Detailers of Fort Myers Opens Locations in Michigan
-
Crypto News: Pepeto Closes In on Its Binance Listing While XRP Price Targets $3.5 Soon
-
Northlight Wine Collective Acquires Meyer Family Vineyards and Mayhem Wines
-
Pure Cycle Corporation Announces Receipt of Notice to Nominate Director Candidates
-
Global Uranium Corp. Announces 10:1 Share Consolidation
-
Stingray to Release its Financial Results for the First Quarter of Fiscal 2027
-
NevGold Announces Change of Auditor and Continuance to British Columbia
-
Penrose Growth Expands Next-Generation Value Creation Platform After Generating More Than $70MM in Incremental Revenue
-
Northview Residential REIT Reports Q2 2026 Financial Results With Steady Revenue Growth Amid Expense Pressures
-
Westhaven Announces Grant of Incentive Stock Options
-
Bugtraq Is Back: The Original Full Disclosure Mailing List Is Live Again
-
MARKSMEN ANNOUNCES PROPOSED PRIVATE PLACEMENT
-
Allied Gold Announces Voting Results From Annual Meeting of Shareholders
-
FitzWalter Capital Selected as Successful Bidder for Mohawk Day Camp
-
Newcore Gold Files Pre-Feasibility Study Technical Report for the Enchi Gold Project, Ghana
-
Nova Leap Health Corp. Posts Record Q2 2026 Revenue, Income from Operating Activities and Adjusted EBITDA
-
Check-Cap Announces Reverse Share Split
-
Univest Securities, LLC Announces Closing of $1.05 Million Registered Direct Offering for its Client YXT.COM GROUP HOLDING Ltd (NASDAQ: YXT)
-
Ashland board authorizes quarterly dividend
-
Citizens Commission on Human Rights International Urges U.S. Action After U.N. Committee Condemns Forced Psychiatric Detention and Treatment
-
Supranext Selects Kore Inside as its Exclusive Platform for Private Placements and Securities Issuance
-
Expion360 Reports Second Quarter 2026 Financial and Operational Results
-
LodgeLink to Present at the Canaccord Genuity 46th Annual Growth Conference
-
-
Birchtech Announces Results of Voting from Annual Meeting of Stockholders
-
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Atico Announces 2026 AGM Voting Results and Stepdown of Michael Winn as Director
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2026
-
Sharplink and Galaxy Digital Launch First-of-Its-Kind $125M Onchain Yield Fund
-
Motorsport Games to Report Second Quarter 2026 Financial Results
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Amwell makes grant to new employees under inducement plan
-
Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference
-
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Parks! America, Inc. Reports Third Quarter Fiscal 2026 Financial Results
-
Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
-
Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026
-
Entera Announces Second Quarter 2026 Financial Results and Business Updates
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2026
-
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
-
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
-
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
